CureMatch, Inc. is a digital health company based in San Diego, CA focused on prediction of personal
Location: United States, California, San Diego
Employees: 11-50
Phone: +1 858-859-2873
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Analytics ... | analyticsv... |
Mentions in press and media 15
| Date | Title | Description |
| 18.01.2024 | CureMatch Welcomes Kimary Kulig, PhD, MPH to Advisory Board | Precision Medicine Pioneer CureMatch Welcomes Oncology Expert Dr. Kimary Kulig to its Advisory Board, Elevating Innovation in Cancer Care. SAN DIEGO, CA, UNITED STATES, January 19, 2024 /EINPresswire.com/ -- CureMatch, a leading innovator i... |
| 31.07.2023 | 4 Ways Biopharma Is Applying AI/ML to Improve Drug Development Outcomes | Healthcare innovation in drug development intersects with a few critical trends: the rise of artificial intelligence (AI) applications in healthcare—particularly machine learning (ML) and predictive analytics; the need to reduce the costs a... |
| 18.07.2023 | Massive Bio and CureMatch Announce Groundbreaking Partnership to Revolutionize Cancer Treatment | Massive Bio & CureMatch Partnership For Cancer Clinical Trial Massive Bio and CureMatch team up to innovate cancer care, accelerating drug development and improving clinical trial access. NEW YORK, NY, UNITED STATES OF AMERICA, July 18,... |
| 06.06.2023 | CureMatch and xCures Partner to Revolutionize the Standard for Precision Cancer Treatment Processes | CureMatch will leverage xCures technology that automatically creates a comprehensive outline of a patient’s medical history to improve treatment recommendations We are confident that we can accelerate the adoption of precision oncology and ... |
| 27.03.2023 | CureMatch and Mprobe Partner to Help Cancer Patients Determine Optimal Treatments | CureMatch will leverage mProbe’s targeted proteomics platform to assess individual proteins within patients’ tumor tissues. We are excited to be partnering with CureMatch to provide proteomic information to CureMatch’s platform for clinical... |
| 04.01.2023 | CureMatch Granted CPT® Code by American Medical Association for its Algorithmic Cancer Therapy Ranking Service | Oncologists will soon be able to submit claims to payers using a Category III CPT code, paving the way for wider adoption of precision treatment options. As a practicing oncologist, I know how crucial it is for physicians to have the tools ... |
| 15.11.2022 | CureMatch Announces the Addition of Dr. Jacob Adashek, Dr. Nader Javadi and Dr. Jason Sicklick to Advisory Board | Dr. Adashek, Dr. Javadi, and Dr. Sicklick bring deep expertise in cancer treatment, precision medicine, and the pharmaceutical field to CureMatch. CureMatch is getting the right drugs to the right patients at the right time. It optimizes cl... |
| 21.07.2022 | CureMatch Announces the Addition of John S. Link, Jordan Schlain and Greg Simon to Advisory Board | Dr. Link, Dr. Schlain and Mr. Simon all bring deep entrepreneurial experience in the medical and pharmaceutical fields to precision medicine. I wrote the book on navigating a breast cancer diagnosis, and I have even benefited from this uniq... |
| 21.06.2022 | CureMatch and Alliance Care Technologies Announce Partnership to Bring Precision Cancer Treatment to More Patients | As new therapies rapidly emerge, the CureMatch Decision Support System will be a critical resource for oncologists who may struggle to stay informed about new therapeutic combinations and trials.” — Michele Tarnow, Founder & CEO of ACTS... |
| 25.08.2020 | Employees social networking platform Mesh secured seed funding from Y Combinator | San Jose based employees social networking start-up, Mesh announced on 20th August, 2020, that it has raised an undisclosed amount of funding from Silicon Valley’s most influential startup incubators, Y Combinator. |
Show more